Back
PharmaCyte Biotech, Inc. Stock Price Chart
Get Your Free Stock Selector Checklist and Invest Smarter
Get Your Free Safe Stock Selector Checklist Now
Buy
73
PMCB
PharmaCyte Biotech, Inc.
Last Price:
$1.14
Seasonality Move:
35.79%
7 Day Trial
ALL ACCESS PASS
$
7
Safe Investing Checklist - Stay Clear of Risky Stocks
Get Your Free Safe Stock Selector Checklist Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PMCB is experiencing slight selling pressure.
PharmaCyte Biotech, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.93 | Buy |
| 20-day SMA: | 0.83 | Buy |
| 50-day SMA: | 0.91 | Buy |
| 200-day SMA: | 1.1 | Buy |
| 8-day EMA: | 0.99 | Buy |
| 20-day EMA: | 0.9 | Buy |
| 50-day EMA: | 0.9 | Buy |
| 200-day EMA: | 1.11 | Buy |
PharmaCyte Biotech, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 65.74 | Buy |
| Chaikin Money Flow: | -121853 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.69 - 0.99) | Buy |
| Bollinger Bands (100): | (0.83 - 1.05) | Buy |
PharmaCyte Biotech, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for PharmaCyte Biotech, Inc. Stock
Is PharmaCyte Biotech, Inc. Stock a Buy?
-
PharmaCyte Biotech, Inc. share price is 1.15 while PMCB 8-day simple moving average is 0.93, which is a Buy signal.
-
The stock price of PMCB is 1.15 while PharmaCyte Biotech, Inc. 20-day SMA is 0.83, which makes it a Buy.
-
PharmaCyte Biotech, Inc. 50-day simple moving average is 0.91 while PMCB share price is 1.15, making it a Buy technically.
-
PMCB stock price is 1.15 and PharmaCyte Biotech, Inc. 200-day simple moving average is 1.10, creating a Buy signal.
PMCB Technical Analysis vs Fundamental Analysis
Buy
73
PharmaCyte Biotech, Inc. (PMCB)
is a Buy
Is PharmaCyte Biotech, Inc. a Buy or a Sell?
-
PharmaCyte Biotech, Inc. stock is rated a BuyThe current PharmaCyte Biotech, Inc. [PMCB] share price is $1.15. The Score for PMCB is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
PharmaCyte Biotech, Inc. Stock Info
Market Cap:
7.8M
Price in USD:
1.15
Share Volume:
2.3M
PharmaCyte Biotech, Inc. 52-Week Range
52-Week High:
1.90
52-Week Low:
0.63
Buy
73
PharmaCyte Biotech, Inc. (PMCB)
is a Buy
PharmaCyte Biotech, Inc. Share Price Forecast
-
What is the PharmaCyte Biotech, Inc. stock price today?The PharmaCyte Biotech, Inc. stock price is 1.15 USD today.
-
Will PMCB stock go up or go down?PharmaCyte Biotech, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is PharmaCyte Biotech, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, PharmaCyte Biotech, Inc. is not overvalued.
Is PharmaCyte Biotech, Inc. Stock a Buy?
-
PharmaCyte Biotech, Inc. share price is 1.15 while PMCB 8-day exponential moving average is 0.99, which is a Buy signal.
-
The stock price of PMCB is 1.15 while PharmaCyte Biotech, Inc. 20-day EMA is 0.90, which makes it a Buy.
-
PharmaCyte Biotech, Inc. 50-day exponential moving average is 0.90 while PMCB share price is 1.15, making it a Buy technically.
-
PMCB stock price is 1.15 and PharmaCyte Biotech, Inc. 200-day simple moving average is 1.11, creating a Buy signal.
Technical Analysis of PharmaCyte Biotech, Inc.
Should I short PharmaCyte Biotech, Inc. stock?
-
PMCB Moving Average Covergence Divergence (MACD) indicator is 0.05, suggesting PharmaCyte Biotech, Inc. is a Buy
-
PharmaCyte Biotech, Inc. Relative Strength Index (RSI) is 65.74, which suggest PharmaCyte Biotech, Inc. is overbought
-
The Bollinger Bands (25) for PharmaCyte Biotech, Inc. is (0.69 - 0.99), which suggest PharmaCyte Biotech, Inc. is a Buy
-
The Bollinger Bands (100) for PharmaCyte Biotech, Inc. is (0.83 - 1.05), which suggest PharmaCyte Biotech, Inc. is a Buy
* PharmaCyte Biotech, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.